Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target

Open access

Abstract

Background: The RNA-binding protein IGF2BP2/IMP2/VICKZ2/p62 is an oncofetal protein that is overexpressed in several cancer entities. Employing IMP2 knockout colorectal cancer cells, we could show the important role of IMP2 in several hallmarks of cancer. This study aimed to functionally characterize IMP2 in lung (A549, LLC1) and hepatocellular carcinoma (HepG2, Huh7) cell lines to assess its role as a potential target for these cancer entities. Methods: IMP2 knockouts were generated by CRISPR/Cas9 and its variant approach prime editing; the editing efficiency of two single guide RNAs (sgRNAs) was verified via next-generation sequencing. We studied the effect of IMP2 knockout on cell proliferation, colony formation, and migration and employed small-molecule inhibitors of IMP2. Results: Despite multiple attempts, it was not possible to generate IMP2 biallelic knockouts in A549 and Huh7 cells. Both sgRNAs showed good editing efficiency. However, edited cells lost their ability to proliferate. The attempt to generate an IMP2 biallelic knockout in LLC1 cells using CRISPR/Cas9 was successful. Monoallelic knockout cell lines of IMP2 showed a reduction in 2D cell proliferation and reduced migration. In 3D cultures, a change in morphology from compact spheroids to loose aggregates and a distinct reduction in the colony formation ability of the IMP2 knockouts was observed, an effect that was mimicked by previously identified IMP2 inhibitor compounds that also showed an inhibitory effect on colony formation. Conclusions: Our in vitro target validation supports that IMP2 is essential for tumor cell proliferation, migration, and colony formation in several cancer entities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31083/j.fbl2901041

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Editing efficiency of gRNA1 and gRNA2 in A549 cells. Panel (A) represents gRNA1-transfected A549 cells analyzed using gRNA1 adapter primers, while panel (B) represents gRNA2-transfected A459 cells using gRNA2 adapter primers. The pie charts display the percentage and number of reads, indicating the presence of unmodified alleles (blue) and modified alleles (orange).
Fig. 1 Editing efficiency of gRNA1 and gRNA2 in A549 cells. Panel (A) represents gRNA1-transfected A549 cells analyzed using gRNA1 adapter primers, while panel (B) represents gRNA2-transfected A459 cells using gRNA2 adapter primers. The pie charts display the percentage and number of reads, indicating the presence of unmodified alleles (blue) and modified alleles (orange).CC-BY · From the PDF
Fig. 2 Editing efficiency of gRNA1 and gRNA2 in combination in Huh7 cells. The sequence alignment with the reference genome is presented in the sequence view. Nucleotides indicated by the pink bar represent the sequencing result. Additionally, the red bar represents a 96 bp deletion between the gRNA1 and gRNA2, represented by blue and green bars, respectively. This deletion occurs in the target region of exon 6 of IGF2BP2 . The image was generated using SnapGene Viewer version 6.2 (San Diego, CA, USA).
Fig. 2 Editing efficiency of gRNA1 and gRNA2 in combination in Huh7 cells. The sequence alignment with the reference genome is presented in the sequence view. Nucleotides indicated by the pink bar represent the sequencing result. Additionally, the red bar represents a 96 bp deletion between the gRNA1 and gRNA2, represented by blue and green bars, respectively. This deletion occurs in the target region of exon 6 of IGF2BP2 . The image was generated using SnapGene Viewer version 6.2 (San Diego, CA, USA).CC-BY · From the PDF
Fig. 3 Effect of IMP2 knockout on 2D cell proliferation. (A) LLC1, (B) Huh7, (C) HepG2, and (D) SW480 were assessed for their effect on 2D cell proliferation using the IncuCyte® S3 live cell imaging system. LLC1 IMP2 knockouts were biallelic (bKO), while the Huh7, HepG2, and SW480 cells were monoallelic IMP2 knockouts (mKO). Data were normalized to time point 0 h and are represented as mean ± SEM, n = 3, quintuplicates. Significance values were determined by comparing the knockout cells to those obtained from the wild-type (WT) cells. The proliferation rate was determined based on cell confluence.
Fig. 3 Effect of IMP2 knockout on 2D cell proliferation. (A) LLC1, (B) Huh7, (C) HepG2, and (D) SW480 were assessed for their effect on 2D cell proliferation using the IncuCyte® S3 live cell imaging system. LLC1 IMP2 knockouts were biallelic (bKO), while the Huh7, HepG2, and SW480 cells were monoallelic IMP2 knockouts (mKO). Data were normalized to time point 0 h and are represented as mean ± SEM, n = 3, quintuplicates. Significance values were determined by comparing the knockout cells to those obtained from the wild-type (WT) cells. The proliferation rate was determined based on cell confluence.CC-BY · From the PDF
Fig. 4 Comparison of spheroid formation between wild-type and IMP2 knockout clones. (A) LLC1, (B) HepG2, and (C) SW480 clones were assessed for their spheroid forming ability using the live cell imaging system IncuCyte® S3 at the 6-day time point after cell seeding. Representative images were chosen, and the scale was adjusted to 1 mm. The Huh7, HepG2, and SW480 IMP2 knockout cells were monoallelic knockouts.
Fig. 4 Comparison of spheroid formation between wild-type and IMP2 knockout clones. (A) LLC1, (B) HepG2, and (C) SW480 clones were assessed for their spheroid forming ability using the live cell imaging system IncuCyte® S3 at the 6-day time point after cell seeding. Representative images were chosen, and the scale was adjusted to 1 mm. The Huh7, HepG2, and SW480 IMP2 knockout cells were monoallelic knockouts.CC-BY · From the PDF
Fig. 5 Effect of IMP2 knockout in LLC1 cells on the colony formation ability. The results are presented as follows: (A) number of colonies, (B) average area of colonies, and (C) representative images of colonies with the scale adjusted to 1 mm. Colony counting and measurement of average area were performed using the IncuCyte® S3 live cell imaging system. It should be noted that WT1 represents the LLC1 wild-type clone, while WT2 serves as the LLC1 editing control. The data was normalized to the WT1 cells and are represented as mean ± SEM, n = 4, triplicates. ** p < 0.01 and *** p < 0.001 when compared to values of WT1 cells. n.s. indicates no significant difference.
Fig. 5 Effect of IMP2 knockout in LLC1 cells on the colony formation ability. The results are presented as follows: (A) number of colonies, (B) average area of colonies, and (C) representative images of colonies with the scale adjusted to 1 mm. Colony counting and measurement of average area were performed using the IncuCyte® S3 live cell imaging system. It should be noted that WT1 represents the LLC1 wild-type clone, while WT2 serves as the LLC1 editing control. The data was normalized to the WT1 cells and are represented as mean ± SEM, n = 4, triplicates. ** p < 0.01 and *** p < 0.001 when compared to values of WT1 cells. n.s. indicates no significant difference.CC-BY · From the PDF
Fig. 6 Effect of IMP2 knockout on colony formation ability of Huh7, HepG2, and SW480. Figures illustrate the number of colonies for wild-type (WT) or monoallelic IMP2 knockout (mKO) (A) Huh7, (B) HepG2, and (C) SW480 cells, and the average area of colonies for (D) Huh7, (E) HepG2, and (F) SW480. (G) Representative images of colonies seen in a 6-well plate. The colonies were counted, and the average colony area was measured using the IncuCyte® S3 live cell imaging system. Huh7, HepG2, and SW480 were monoallelic IMP2 knockouts. Data were normalized to wild-type cells/control (Co) and represented as mean ± SEM, n = 3, duplicates. * p < 0.05 and *** p < 0.001 when compared to values of control.
Fig. 6 Effect of IMP2 knockout on colony formation ability of Huh7, HepG2, and SW480. Figures illustrate the number of colonies for wild-type (WT) or monoallelic IMP2 knockout (mKO) (A) Huh7, (B) HepG2, and (C) SW480 cells, and the average area of colonies for (D) Huh7, (E) HepG2, and (F) SW480. (G) Representative images of colonies seen in a 6-well plate. The colonies were counted, and the average colony area was measured using the IncuCyte® S3 live cell imaging system. Huh7, HepG2, and SW480 were monoallelic IMP2 knockouts. Data were normalized to wild-type cells/control (Co) and represented as mean ± SEM, n = 3, duplicates. * p < 0.05 and *** p < 0.001 when compared to values of control.CC-BY · From the PDF
Image 7
CC-BY · From the PDF
Image 8
CC-BY · From the PDF
Fig. 9 Effect of IMP2 inhibitors on wild-type LLC1 cells in colony formation assay. Figures illustrate the (A) number of colonies, (B) average area of colonies, and (C) representative images of colonies seen in a 6-well plate. Colonies were counted, and the average area of colonies was determined using the IncuCyte® S3 live cell imaging system. A treatment concentration of 25 µM was applied for each compound. Data was normalized to untreated wild-type LLC1 cells/control (Co) and represented as mean ± SEM, n = 3, duplicates. * p < 0.05 and ** p < 0.01 when compared to values of control cells.
Fig. 9 Effect of IMP2 inhibitors on wild-type LLC1 cells in colony formation assay. Figures illustrate the (A) number of colonies, (B) average area of colonies, and (C) representative images of colonies seen in a 6-well plate. Colonies were counted, and the average area of colonies was determined using the IncuCyte® S3 live cell imaging system. A treatment concentration of 25 µM was applied for each compound. Data was normalized to untreated wild-type LLC1 cells/control (Co) and represented as mean ± SEM, n = 3, duplicates. * p < 0.05 and ** p < 0.01 when compared to values of control cells.CC-BY · From the PDF
Fig. 10 Effect of IMP2 inhibitors on Huh7, HepG2, and SW480 cells in colony formation assays. Results present the number of colonies for (A) Huh7, (B) HepG2, and (C) SW480, as well as the average area of colonies for (D) Huh7, (E) HepG2, and (F) SW480 cells. Additionally, (G) representative images of colonies are shown as seen in a 6-well plate. The colonies were counted, and the average colony area was determined using a live cell imaging system, IncuCyte® S3. The Huh7, HepG2, and SW480 were monoallelic IMP2 knockouts. Data was normalized to untreated wild-type cells and represented as mean ± SEM, n = 2, triplicates. The treatment doses were as follows: For Huh7, comp 4: 35 µM, comp 6: 45 µM, and comp 9: 25 µM. For HepG2, comp 4: 30 µM, comp 6: 40 µM, and comp 9: 35 µM. For SW480, comp 4: 20 µM, comp 6: 50 µM, and comp 9: 35 µM. * p < 0.05, ** p < 0.01, and *** p < 0.001 when compared to values of respective wild-type (WT)/control (Co) cells.
Fig. 10 Effect of IMP2 inhibitors on Huh7, HepG2, and SW480 cells in colony formation assays. Results present the number of colonies for (A) Huh7, (B) HepG2, and (C) SW480, as well as the average area of colonies for (D) Huh7, (E) HepG2, and (F) SW480 cells. Additionally, (G) representative images of colonies are shown as seen in a 6-well plate. The colonies were counted, and the average colony area was determined using a live cell imaging system, IncuCyte® S3. The Huh7, HepG2, and SW480 were monoallelic IMP2 knockouts. Data was normalized to untreated wild-type cells and represented as mean ± SEM, n = 2, triplicates. The treatment doses were as follows: For Huh7, comp 4: 35 µM, comp 6: 45 µM, and comp 9: 25 µM. For HepG2, comp 4: 30 µM, comp 6: 40 µM, and comp 9: 35 µM. For SW480, comp 4: 20 µM, comp 6: 50 µM, and comp 9: 35 µM. * p < 0.05, ** p < 0.01, and *** p < 0.001 when compared to values of respective wild-type (WT)/control (Co) cells.CC-BY · From the PDF
Fig. 11 Effect of IMP2 knockout on cell migration in a wound healing assay. (A) LLC1 (B) Huh7, (C) HepG2, and (D) SW480 cells were analyzed for cell migration using the IncuCyte® S3 system over a 48 h period. Representative pictures show the wound area in color at the starting point, 0 h, and 48 h after wounding, and the scale was set to 1 mm. The LLC1 wild-type clone is referred to as WT1, and the LLC1 editing control is referred to as WT2. The Huh7, HepG2, and SW480 were monoallelic IMP2 knockouts. Data are normalized to time point 0 h. Data is represented as mean ± SEM, n = 3 (quintuplicates). Panels (B-D) display p -values for WT vs. KO cells.
Fig. 11 Effect of IMP2 knockout on cell migration in a wound healing assay. (A) LLC1 (B) Huh7, (C) HepG2, and (D) SW480 cells were analyzed for cell migration using the IncuCyte® S3 system over a 48 h period. Representative pictures show the wound area in color at the starting point, 0 h, and 48 h after wounding, and the scale was set to 1 mm. The LLC1 wild-type clone is referred to as WT1, and the LLC1 editing control is referred to as WT2. The Huh7, HepG2, and SW480 were monoallelic IMP2 knockouts. Data are normalized to time point 0 h. Data is represented as mean ± SEM, n = 3 (quintuplicates). Panels (B-D) display p -values for WT vs. KO cells.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 8

Metadata

Authors
Chanda, S., Lepikhov, K., Dahlem, C., Schymik, H. S., Hoppstädter, J., Geber, A.-K., Wagner, K., Kessler, S. M., Empting, M., & Kiemer, A. K.
Affiliations
  • Saarland University (DE)
  • Helmholtz Institute for Pharmaceutical Research Saarland (DE)
  • Martin Luther University Halle-Wittenberg (DE)
Corresponding author
Kiemer, Alexandra K.
Venue
Frontiers in Bioscience-Landmark
Publisher
IMR Press
Published
2024-01-23
Volume
29
Issue
1
Pages
41-41
ISSN
  • 2768-6698 (ISSN-L)
  • 2768-6701
OpenAlex
W4391151624
Cited by
8
References
38
Citations by year
2026: 2 · 2025: 4 · 2024: 2
FWCI
1.04
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioscience-Landmark (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Publications of the UdS (Saarland University) (cc-by)
Funders
German Research Foundation (DFG, KI702)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
RNA-binding proteins, oncofetal protein, cancer drug targets, CRISPR/Cas9, prime editing, small molecule inhibitors, lung cancer, hepatocellular carcinoma, colorectal cancer, cell proliferation, cell migration, colony formation, tumor spheroids, target validation
MeSH terms
Gene Editing, RNA, Guide, CRISPR-Cas Systems, Antineoplastic Agents, Humans, Liver Neoplasms, RNA-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target. https://app.cochat.ai/papers/10.31083/j.fbl2901041
The paper
Chanda, S., Lepikhov, K., Dahlem, C., Schymik, H. S., Hoppstädter, J., Geber, A.-K., Wagner, K., Kessler, S. M., Empting, M., & Kiemer, A. K. (2024). Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2901041

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.